Merck Takes A New Shot At Alzheimer’s With Cerevance Deal

Pays $25m Upfront

Man with Alzheimer's disease
An Estimated 6.5 Million People In The US Have Alzheimer's Disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business